510(k) Report

510(k) · Cleared

Cleared

Presygen/si-1

K171245510(k) TraditionalCleared Aug 9, 2018468-day reviewClass II21 CFR 870.2700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Christie Medical Holdings, Inc. · MUD Oximeter, Tissue Saturation

Cleared on Aug 9, 2018 as substantially equivalent to K113507 (Kent Imaging, Inc., 2012) after a 468-day review. Its family tree reaches back 8 generations to 1998.

Decided
Aug 9, 2018
Review
468 days
Class
Class II
Product code
MUD
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K963903 (1998). No later device cites it as a predicate yet.

  1. Root · 8 generations backK963903 Biospectrometer-NB Oximeter IiiiHutchinson Technology, Inc. · 1998
  2. 7 generations backK012759 Inspectra Tissue Spectrometer System (Inspectra), Model 325Hutchinson Technology, Inc. · 2002
  3. 6 generations backK023938 Modification to Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc. · 2002
  4. 5 generations backK042020 Spectra Tissue Spectrometer System (Inspectra)Hutchinson Technology, Inc. · 2004
  5. 4 generations backK053618 Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc. · 2006
  6. 3 generations backK061848 Hyperspectral Tissue Oxygenation Measurement System, Model Oxy VU1Hypermed, Inc. · 2006
  7. 2 generations backK073656 Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement SystemHypermed, Inc. · 2008
  8. 1 generation backK113507 Kent CameraKent Imaging, Inc. · 2012
  9. This deviceK171245 Presygen/si-1Christie Medical Holdings, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K963903Biospectrometer-NB Oximeter IiiiHutchinson Technology, Inc.1998—
−7K012759Inspectra Tissue Spectrometer System (Inspectra), Model 325Hutchinson Technology, Inc.2002—
−6K023938Modification to Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc.2002—
−5K042020Spectra Tissue Spectrometer System (Inspectra)Hutchinson Technology, Inc.2004—
−4K053618Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc.2006—
−3K061848Hyperspectral Tissue Oxygenation Measurement System, Model Oxy VU1Hypermed, Inc.2006—
−2K073656Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement SystemHypermed, Inc.2008—
−1K113507Kent CameraKent Imaging, Inc.2012—
0 (this device)K171245Presygen/si-1Christie Medical Holdings, Inc.2018—
FIG. 1 — Lineage of K171245, 1998–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUD device

  1. #1 K223651 Cerebral Adaptive Index (CAI) Algorithmscore 19.8 · 29 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113507Kent Camera
Summary page 4
…MUD Panel: Cardiovascular 3. PREDICATE DEVICE AND REFERENCE DEVICE The predicate device is Kent Camera (Kent Imaging, Inc., K113507). The reference device is T.Ox™ (Vioptix, Inc., K042657). 4. DESCRIPTION OF THE DEVICE Presygen™/si-1 is a standalone, non-c…
Kent Imaging, Inc.2012—
†K042657Vioptix Odissey Tissue Oximeter Tissue Oximeter, Model Oxy-2Vioptix, Inc.2005—

Also cleared against K113507: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 1.8 years on median.
  • None of the 8 ancestors has a recall.
  • 1 other device also cites its predicate K113507.

How does its category compare?

All MUD devices

MUD Oximeter, Tissue Saturation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · MUD

2in 2025

2008: 42009: 42010: 42011: 22012: 62013: 22014: 52015: 32016: 42017: 32018: 32019: 72020: 22021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 7 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUD

124in 2024

2008: 72 days median2009: 96 days median2010: 59 days median2012: 211 days median2014: 109 days median2015: 107 days median2016: 167 days median2017: 249 days median2018: 128 days median2019: 88 days median2024: 124 days median
2007high 249 (2017) · low 59 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUD

1in 2023

2009: 12022: 22023: 12026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUD

131in 2025

2008: 22009: 72010: 12011: 22012: 32013: 82014: 42016: 92017: 242018: 382019: 1072020: 502021: 272022: 522023: 732024: 1402025: 131
2007high 140 (2024) · low 0 (2007)2025

MAUDE reports naming product code MUD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200847202
200949617
201045901
20112—02
2012621103
20132—08
2014510904
2015310700
2016416709
20173249024
20183128038
20197880107
20202—050
20212—027
20222—252
20232—173
202451240140
20252—0131
20261—1—

What is it indicated for?

Presygen™/si-1 is indicated for use in hospital facilities, along with clinical assessment of signs and symptoms, by healthcare professionals for non-invasive and non-diagnostic measure of relative temporal variation in oxygen saturation (StO2) in superficial tissue. Presygen™/si-1 displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports tissue oxygenation measurements in selected tissue regions. Presygen™/si-1 is intended for adults only (22 and over).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171245: Presygen/si-1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171245

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026